Titan Pharmaceuticals, Inc. Press Releases

TTNP 
$3.84
*  
0.06
1.59%
Get TTNP Alerts
*Delayed - data as of Feb. 5, 2016  -  Find a broker to begin trading TTNP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

Titan Pharmaceuticals and Braeburn Pharmaceuticals Announce FDA Advisory Committee Recommends Approval of Probuphine, First 6-Month Implant to Treat Opioid Addiction
1/12/2016 7:20:00 PM - PR Newswire
▲28.00 % Price Change since this news event. The Volume Ratio is 9.38.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Trading of Titan Pharmaceuticals Stock Halted Today
1/12/2016 7:05:00 AM - Market Wire


Trading of Titan Pharmaceuticals Stock Halted Today
1/12/2016 7:05:00 AM - Market Wire




Braeburn Pharmaceuticals And Titan Pharmaceuticals Announce Date Of FDA Advisory Committee Review Of Probuphine For Opioid Addiction
12/9/2015 7:00:00 AM - PR Newswire
▼-27.55 % Price Change since this news event. The Volume Ratio is 4.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Titan Pharmaceuticals and Braeburn Pharmaceuticals Announce Date of FDA Advisory Committee Review of Probuphine for Opioid Addiction
12/9/2015 7:00:00 AM - Market Wire
▼-27.55 % Price Change since this news event. The Volume Ratio is 4.76.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day









Learn more by visiting our FAQ page